ARDS
[대역어] 성 호흡곤란 증후군
[용어속성] Disease
[용어속성] Disease
Ferritin, blood urea nitrogen, and high chest CT score determines ICU admission in COVID-19 positive UAE patients: A single center retrospective study
페리틴, 혈액 요소 질소 및 높은 흉부 CT 점수가 COVID-19 양성 UAE 환자의 ICU 입원을 결정합니다: 단일 센터 후향적 연구
Article
[키워드] Accuracy
acute respiratory distress
acute respiratory distress syndrome
Admission
affected
Analysis
analyzed
ARDS
benefit
biochemical
biochemical parameter
Biochemical parameters
Blood urea nitrogen
C-reactive protein
Care
carried
Chest CT
clinical parameter
Clinical parameters
clinical presentation
Clinical presentations
Combination
coronavirus disease
Course
COVID-19
COVID-19 infected patient
COVID-19 infected patients
COVID-19 patient
COVID-19 patients
D-dimer
determine
Factor
ferritin
Healthcare system
hospital
hospital care
ICU
ICU admission
indicated
infected patients
intensive care
MOST
nitrogen
Novel coronavirus
pandemic
Patient
positive
positive correlation
predict
radiological
respiratory distress
Retrospective study
ROC
sensitivity
Severity of infection
Sharjah
single center
specificity
statistical analysis
syndrome
the disease
the patient
university
urea
variant
WHO
[DOI] 10.1371/journal.pone.0269185 PMC 바로가기 [Article Type] Article
[DOI] 10.1371/journal.pone.0269185 PMC 바로가기 [Article Type] Article
Neddylation tunes peripheral blood mononuclear cells immune response in COVID-19 patients
Research
[키워드] activated
Activation
acute respiratory distress
acute respiratory syndrome
addition
approach
ARDS
avoidance
caused
contagious
Control
cough
COVID-19
COVID-19 pandemic
COVID-19 patient
COVID-19 patients
Critical
cytokine production
Cytokine storm
death
develop
early response
effective
exacerbated
Fever
hospitalized patient
IL-6
immune response
immune system
implication
in viral
include
increase in
induce
Infection
inhibition
MCP-1
mechanism
modulation
mononuclear cell
pathology
Patient
patients
PBMCs
Peripheral blood
Pneumonia
post-translational modification
previous study
proliferation
Protein
proteome
reached
reduce
regulate
SARS-CoV-2
serum
severe pneumonia
stability
subsequent
syndrome
systemic inflammation
therapeutic
Vaccine
viral infection
[DOI] 10.1038/s41420-022-01115-0 [Article Type] Research
[DOI] 10.1038/s41420-022-01115-0 [Article Type] Research
Does awake prone positioning prevent the use of mechanical respiratory support or death in COVID-19 patients on standard oxygen therapy hospitalised in general wards? A multicentre randomised controlled trial: the PROVID-19 protocol
깨어 있는 엎드린 자세가 일반 병동에 입원한 표준 산소 요법을 받는 COVID-19 환자의 기계적 호흡 지원 또는 사망을 방지합니까? 다기관 무작위 대조 시험: PROVID-19 프로토콜
Article
[키워드] acute respiratory distress
acute respiratory distress syndrome
approved
ARDS
Awake prone positioning
body mass
body mass index
composite endpoint
COVID-19
COVID-19 patient
COVID-19 patients
death
death in COVID-19
decrease
defined
Ethics
France
hospitalised
hypothesised
hypoxaemia
IMPROVE
Infectious diseases
Informed consent
intervention group
intubation
investigator-initiated
mechanical respiratory
multicentre
Non-intubated
non-invasive ventilation
Noninvasive ventilation
Oxygenation
Patient
patients with ARDS
peer-reviewed
Prevent
prone
Prone position
prone positioning
protocol
randomised
randomised controlled
receive
registration number
respiratory distress
Respiratory distress syndrome
respiratory infections
responsible
Safe
severity
Standard of care
standard oxygen therapy
Stratification
submitted
Support
survival
syndrome
the ethics committee
Treatment
treatment failure
Trial
usual care
usual care alone
[DOI] 10.1136/bmjopen-2021-060320 PMC 바로가기 [Article Type] Article
[DOI] 10.1136/bmjopen-2021-060320 PMC 바로가기 [Article Type] Article
Exposure modality influences viral kinetics but not respiratory outcome of COVID-19 in multiple nonhuman primate species
노출 방식은 여러 비인간 영장류 종에서 바이러스 역학에 영향을 미치지만 COVID-19의 호흡기 결과에는 영향을 미치지 않습니다
Article
[키워드] aerosol exposure
African
African green monkeys
AGM
AGMs
animal model
animal models
ARDS
change
Characteristics
Chlorocebus
clinical
clinical response
Clinical sign
Clinical signs
Cohort
conserved
COVID-19
COVID-19 disease
cytokine response
demonstrated
demonstration
develop
expand
exposure
functional
greater
include
infected with SARS-CoV-2
Infection
influence
intranasal
lack
lung damage
magnitude
Medical countermeasures
mucosal
mucosal exposure
myeloid cell
Novel coronavirus
novel coronavirus SARS-CoV-2
outcome
pandemic status
Pathogenesis
Pathologies
pleuritis
Pulmonary pathology
reached
regenerative
Research
rhesus
rhesus macaques
route
SARS-COV-2 infection
severe disease
small particle aerosol
species
tested
therapeutic
utility
variants
variants of concern
viral kinetics
Viral load
[DOI] 10.1371/journal.ppat.1010618 PMC 바로가기 [Article Type] Article
[DOI] 10.1371/journal.ppat.1010618 PMC 바로가기 [Article Type] Article
Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial
Clinical Trial
[키워드] acute respiratory distress
acute respiratory distress syndrome
adverse effect
ARDS
bone
Bone marrow
cells
cellular
cellular therapy
clinical
Cohort
control patient
control patients
COVID-19
COVID-19 disease
Critical
D-dimer value
Dexamethasone
Efficacy
Endocarditis
evaluate
extracorporeal membrane oxygenation
group
high mortality
High-flow nasal oxygen
Immune cell
Immune-mediated
induce
Inflammation
Inflammatory response
intensive care
intensive care unit (ICU)
interval
intravenous infusion
invasive
Invasive mechanical ventilation
limit
mechanical ventilation
median
Mesenchymal stromal cells
MSC
MSC-treated
MSCs
nasal
no significant difference
observation
outcome
oxygen
Patient
patients
phase
phenotype
Randomized controlled trial
Regulatory
reported
required
requiring supplemental oxygen
Result
Safe
SARS-CoV-2
severe COVID-19
significantly higher
significantly lower
Statistical tests
stimulate
stroke
stromal cell
survival
syndrome
therapy
tissue repair
treated
Trial
[DOI] 10.3389/fimmu.2022.932360 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.3389/fimmu.2022.932360 PMC 바로가기 [Article Type] Clinical Trial
Response to PEEP in COVID-19 ARDS patients with and without extracorporeal membrane oxygenation. A multicenter case-control computed tomography study
Observational Study
[키워드] adverse effect
alveolar
appear
ARDS
ARDS patients
benefit
Case-control
case-control study
Computed tomography
conducted
COVID-19
COVID-19 ARDS patient
ECMO
extracorporeal membrane oxygenation
fraction
greater
logarithm
lung
lung collapse
Lung recruitability
median
moderate
multicenter
not significantly different
Patient
patients
PEEP
PEEP.
Pneumonia
Recruitability
recruitment
required
response
severe ARDS
severe COVID-19 patient
significantly
significantly higher
significantly lower
Total
variations
[DOI] 10.1186/s13054-022-04076-z PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1186/s13054-022-04076-z PMC 바로가기 [Article Type] Observational Study
Incidence and effects of deep vein thrombosis on the outcome of patients with coronavirus disease 2019 infection
Observational Study
[키워드] 95% CI
95% confidence interval
adjusted
age
Analysis
anticoagulation
ARDS
Characteristics
comparison
contributing to
coronavirus disease
COVID-19
COVID-19 group
COVID-19 patient
COVID-19 patients
Deep vein
Deep vein thrombosis
determine
distress
DVT
Effect
Factor
ICU
ICU Patients
incidence
increased mortality
Infection
intensive care
Limited
male
Mortality
multiple organ failure
non-COVID-19 patient
Observational cohort study
occur
outcome
outcomes
Patient
patients with COVID-19
patients without COVID-19
performed
Primary outcome
Prophylactic
receiving
reported
retrospective
risk factor
Standard
Standard-dose
surgical
syndrome
therapy
Thromboprophylaxis
thrombosis
trauma
trauma patient
treated
ventilatory support
[DOI] 10.1016/j.jvsv.2021.10.013 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1016/j.jvsv.2021.10.013 PMC 바로가기 [Article Type] Observational Study
Clinical progress in MSC-based therapies for the management of severe COVID-19
Mini review
[키워드] MB-MSCs
Menstrual blood-derived Mesenchymal Stromal Cells
3-dioxygenase
ACE2angiotensin converting enzyme 2
acute graft-versus-host disease
acute respiratory distress syndrome
Adipose Tissue derived Mesenchymal Stromal Cells
admadministration
administration
alanine aminotransferase
Allo-MSCsAllogeneic Mesenchymal Stromal Cells
Alloallogeneic
Allogeneic
Allogeneic Mesenchymal Stromal Cells
ALTalanine aminotransferase
angiotensin converting enzyme 2
anti-inflammatory property
ARDS
ARDSacute respiratory distress syndrome
Aspartate aminotransferase
ASTaspartate aminotransferase
AT-MSCsAdipose Tissue derived Mesenchymal Stromal Cells
AT2type 2 alveolar cells of the lungs
BALFbronchoalveolar lavage fluid
BM-MSCsbone marrow derived MSCs
body weight
bone marrow derived MSCs
Bronchoalveolar lavage fluid
bwBody weight
C-reactive protein
cAMPcyclic adenosine monophosphate
candidate
CDcluster of differentiation
Cell
clinical
clinical trial
cluster of differentiation
complex
conducted
Coronavirus disease 2019
coronavirus disease of 2019
COVID-19
COVID-19Coronavirus disease of 2019
CRPC-reactive protein
cyclic adenosine monophosphate
cytokine
Daewoong Pharmaceutical’s Mesenchymal Stromal Cells
DCsdendritic cells
dendritic cells
driven by
DSCsPlacenta-derived decidua stromal cells
DW-MSCsDaewoong Pharmaceutical’s Mesenchymal Stromal Cells
EVsextracellular vesicles
Extracellular vesicles
Fas ligands
Fas-LFas ligands
FDAFood and Drug Administration
FGFfibroblast growth factor
fibroblast growth factor
Food and Drug Administration
forkhead box P3 +
FOXP3 +forkhead box P3 +
G-CSFgranulocyte colony-stimulating factor
Gal-1galectin-1
Gal-3galectin-3
Gal-9galectin-9
galectin-1
galectin-3
Galectin-9
GM-CSFgranulocyte macrophage-colony stimulating factor
granulocyte colony-stimulating factor
granulocyte macrophage-colony stimulating factor
growth factor
GvHDacute graft-versus-host disease
HB-AT-MSCsHope Biosciences autologous adipose-derived mesenchymal stromal cells
HdHigh dose
hepatocyte growth factor
HGFhepatocyte growth factor
High dose
HLAHuman leukocyte antigen
Hope Biosciences autologous adipose-derived mesenchymal stromal cells
human leukocyte antigen
ICUIntensive Care Unit
IDOIndoleamine 2
IFN-γinterferon-γ
IL-10interleukin-10
IL-1interleukin-1
IL-1βinterleukin-1β
IL-2 receptor
IL-2interleukin-2
IL-2RIL-2 receptor
IL-4interleukin-4
IL-6interleukin-6
IL-7Interleukin 7
IL-7interleukin-7
IL-8interleukin 8
IL-9interleukin
IL1-αinterleukin 1-α
IL1-βinterleukin 1-β
IL1RaInterleukin-1 receptor antagonist
immune dysregulation
immunological
immunomodulatory
IMVInvasive mechanical ventilation
Indoleamine 2
inducible protein 10
inflammatory process
inhalation
INHinhalation
intensive care unit
interferon-γ
interleukin
interleukin 1-α
interleukin 1-β
Interleukin 7
interleukin 8
interleukin-1
Interleukin-1 receptor antagonist
interleukin-10
interleukin-1β
interleukin-2
Interleukin-4
interleukin-6
interleukin-7
intravenous
Invasive mechanical ventilation
IP-10inducible protein 10
IVintravenous
keratinocyte growth factor
KGFkeratinocyte growth factor
lactate dehydrogenase
LDHlactate dehydrogenase
LdLow dose
lipopolysaccharide
low dose
LPSlipopolysaccharide
major histocompatibility complex
management
MAPKmitogen-activated protein kinase
MCP-1monocyte chemoattractant protein-1
Mesenchymal stromal cell
Mesenchymal stromal cells
MHCMajor Histocompatibility Complex
microRNA
miRNAmicroRNA
MIS-Cmultisystem inflammatory syndrome in children
mitogen-activated protein kinase
monocyte chemoattractant protein-1
MSCs
MSCsmesenchymal stromal cells
multisystem inflammatory syndrome in children
nanovesicles
National Institutes of Health
natural
NETsNeutrophil Extracellular Traps
Neutrophil extracellular traps
NF-κBnuclear factor-kappa B
NIHNational Institutes of Health
nitric oxide
NKnatural
NONitric Oxide
nuclear factor-kappa B
NVsnanovesicles
occur
PD-1programmed cell death protein 1
PD-L1programmed death ligand-1
PGE2prostaglandin E2
pharmacological management
PL-MSCsPlacental-derived Mesenchymal Stromal Cells
Placenta-derived decidua stromal cells
placental expanded
Placental-derived Mesenchymal Stromal Cells
PLX-PADplacental expanded
programmed cell death protein 1
programmed death ligand-1
prostaglandin E2
protein spike
public health
reactive oxygen species
Regulatory T cell
Respiratory failure
RFrespiratory failure
ROSreactive oxygen species
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
Secretome
severe acute respiratory syndrome coronavirus 2
severe COVID-19
Severe respiratory distress
signal transducer activators of transcription-3
Sprotein spike
STAT3signal transducer activators of transcription-3
syndrome
TGF-β1transforming growth factor-β1
TGFtransforming growth factor
the cytokine storm
the disease
therapeutic
therapy
TLRtoll-like receptors
TNF-α-stimulating gene 6
TNF-αtumor necrosis factor-α
TNFTumor Necrosis Factor
Toll-like receptors
transforming growth factor
transforming growth factor-β1
treat
Tregregulatory T cell
TSG-6TNF-α-stimulating gene 6
tumor necrosis factor
tumor necrosis factor-α
type 2 alveolar cells of the lungs
UC-MSCsumbilical cord derived MSCs
umbilical cord derived MSCs
vascular endothelial growth factor
VEGFvascular endothelial growth factor
Wharton’s Jelly–derived Mesenchymal Stromal Cells
WJ-MSCsWharton’s Jelly–derived Mesenchymal Stromal Cells
[DOI] 10.1016/j.cytogfr.2022.07.002 [Article Type] Mini review
[DOI] 10.1016/j.cytogfr.2022.07.002 [Article Type] Mini review
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness
케모카인, 가용성 PD-L1 및 면역 세포 저반응은 SARS-CoV-2 중병의 뚜렷한 특징입니다
Article
Published on
Journal: American journal of physiology. Lung cellular and [Category] COVID19(2023년), MERS, SARS, 진단,
Journal: American journal of physiology. Lung cellular and [Category] COVID19(2023년), MERS, SARS, 진단,
[키워드] acute respiratory syndrome
ARDS
C-reactive protein
CCL17
CCL26
cellular
checkpoint pathway
chemoattractant
comparison
coronavirus disease
Coronavirus-2
COVID-19
Critical
Critically ill patient
CRP
CXCL10
demographics
enrolled
feature
hyporesponsiveness
identify
IFN-γ
IL-10
IL-17A
IL-6
IL-8
immune
Immune cell
immune signature
in vitro
Interaction
less
lymphocyte
Migration
molecular
monocyte
mortality rate
multisite
not significantly different
p value
Patient
patients
patients without COVID-19
PD-L1
plasma
Pneumonia
profile
prospective cohort
Regulatory
SARS-CoV-2
SARS-CoV-2-positive patient
SARS-CoV-2-positive patients
Sepsis
severe respiratory failure
severity
subject
subjects
T cell
T-cell
TNF-α
two groups
ventilator-free day
with COVID-19
[DOI] 10.1152/ajplung.00049.2022 PMC 바로가기 [Article Type] Article
[DOI] 10.1152/ajplung.00049.2022 PMC 바로가기 [Article Type] Article